J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Medical Genetics 2005;42:e57; doi:10.1136/jmg.2005.033530
Copyright © 2005 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vu, D
Right arrow Articles by Neerman-Arbez, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vu, D
Right arrow Articles by Neerman-Arbez, M
Topic Collections
Right arrow JMG Online mutation reports

ONLINE MUTATION REPORT

Hypofibrinogenaemia caused by a novel FGG missense mutation (W253C) in the {gamma} chain globular domain impairing fibrinogen secretion

D Vu1, P de Moerloose2, A Batorova3, J Lazur4, L Palumbo1, M Neerman-Arbez1

1 Department of Genetic Medicine and Development, University Medical School, Geneva, Switzerland
2 Division of Angiology and Haemostasis, University Hospital, Geneva
3 National Haemophilia Centre, Department of Haematology, University Hospital, Bratislava, Slovakia
4 Department of Haematology, University Hospital, Kosice, Slovakia

Correspondence to:
Professor Marguerite Neerman-Arbez
Centre Médical Universitaire, 1 rue Michel-Servet, CH-1211 Geneva, Switzerland; Marguerite.Arbez{at}medecine.unige.ch] Background: Inherited disorders of fibrinogen are rare and affect either the quantity (hypofibrinogenaemia and afibrinogenaemia) or the quality of the circulating fibrinogen (dysfibrinogenaemia). Extensive allelic heterogeneity has been found for all three disorders: in congenital afibrinogenaemia >30 mutations, the majority in FGA, have been identified in homozygosity or in compound heterozygosity. Several mutations have also been identified in patients with hypofibrinogenaemia; many of these are heterozygous carriers of afibrinogenaemia null mutations.

Objective: To report the case of a patient from Slovakia diagnosed with hypofibrinogenaemia characterised by fibrinogen concentrations of around 0.7 g/l.

Results: The patient was found to be heterozygous for a novel missense mutation W253C (W227C in the mature protein) in the C-terminal globular domain of the fibrinogen {gamma} chain. Co-expression of the W253C FGG mutant cDNA (fibrinogen Bratislava) in combination with wild-type FGA and FGB cDNAs showed that fibrinogen molecules containing the mutant {gamma} chain can assemble intracellularly but are not secreted into the media, confirming the causative nature of the identified mutation.

Conclusions: Current analysis of fibrinogen Bratislava indicates that the domains important for the processes of hexamer assembly and hexamer secretion should not be considered as strictly restricted to one or other fibrinogen chain.


Abbreviations: ATG, annotated translation start codon; CHO, Chinese hamster ovary

Keywords: missense mutation; fibrinogen assembly; fibrinogen secretion




This article has been cited by other articles:


Home page
haematolHome page
D. Vu, C. Di Sanza, and M. Neerman-Arbez
Manipulating the quality control pathway in transfected cells: low temperature allows rescue of secretion-defective fibrinogen mutants
Haematologica, February 1, 2008; 93(2): 224 - 231.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd.